What is the dosage of Remicade?

Remicade is available in 1 dosages, including 100 mg Injection

What does Remicade treat?

Remicade treats Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease, Ankylosing Spondylitis and Psoriatic Arthritis

What is Remicade made of?

Remicade contains infliximab which is a Tumor Necrosis Factor Blocker

How is Remicade administered?

Remicade is administered as a Injectable

What is Remicade mechanism of action?

Remicade mechanism of action is Tumor Necrosis Factor Receptor Blocking Activity

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education People also ask

Remicade

(infliximab)

Remicade 100 MG Injection

BOXED WARNING

Dosage & administration

* Prior to treatment, ensure appropriate personnel and medication are available to treat reactions (e.g., hypersensitivity) that occur during infusion and shortly after infusion
* REMICADE is administered by intravenous infusion for at least 2 hours with an in-line filter
* Crohn's Disease: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some adult patients who initially respond to treatment may benefit from increasing the dose to 10 mg/kg every 8 weeks if they later lose their response.
* Pediatric Crohn's Disease (≥ 6 years old): 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.
* Ulcerative Colitis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.
* Pediatric Ulcerative Colitis (≥ 6 years old): 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.
* Rheumatoid Arthritis: In conjunction with methotrexate, 3 mg/kg at 0, 2 and 6 weeks, then every 8 weeks. Some patients may benefit from increasing the dose up to 10 mg/kg every 8 weeks or treating as often as every 4 weeks.
* Ankylosing Spondylitis: 5 mg/kg at 0, 2 and 6 weeks, then every 6 weeks.
* Psoriatic Arthritis and Plaque Psoriasis: 5 mg/kg at 0, 2 and 6 weeks, then every 8 weeks.

drug label

Remicade prescribing information

Report Adverse Event

prior authorization

Remicade prior authorization resources

Most recent Remicade prior authorization forms

View By Payer

Verified: Dec 03, 2023Highmark BCBS Northeastern NY - Outpatient Infliximab Prior Authorization Form (Medical Benefit)

Verified: Dec 03, 2023Highmark BCBS Western NY - Outpatient Infliximab Prior Authorization Form (Medical Benefit)

Verified: Dec 02, 2023Highmark BCBS West Virginia - Outpatient Infliximab Prior Authorization Form (Medical Benefit)

Verified: Dec 02, 2023Highmark BCBS Delaware - Outpatient Infliximab Prior Authorization Form (Medical Benefit)

Verified: Dec 02, 2023Highmark BCBS Central PA - Outpatient Infliximab Prior Authorization Form (Medical Benefit)

Verified: Dec 01, 2023Highmark BCBS Western PA - Outpatient Infliximab Prior Authorization Form (Medical Benefit)

Verified: Dec 01, 2023Blue Cross Blue Shield of Michigan - FEP Infliximab Biosimilar Prior Authorization Form (Medical Benefit)

Verified: Nov 26, 2023Cigna - Infliximab Biosimilar Prior Authorization Form

Verified: Nov 25, 2023Blue Cross Blue Shield of Michigan - Infliximab Products Prior Authorization Form (Medical Benefit)

Verified: Nov 20, 2023Aetna - Remicade Prior Authorization Form

Complete Letter of Medical Necessity

Coverage Authorization Appeals

Learn More

Benefits investigation

Janssen CarePath IV Benefits Investigation & Enrollment Form

Janssen CarePath Benefits Investigation & Enrollment Form - Gastroenterology

Remicade Benefit Investigation Form

Patient Authorization Form - To be Signed by Patient if HCP Office has no BAA with Janssen

Learn More

financial assistance

Remicade financial assistance options

Co-pay savings program

commercial only

Janssen CarePath IV Benefits Investigation & Enrollment Form

Janssen CarePath Benefits Investigation & Enrollment Form - Gastroenterology

Patient Authorization Form - To be Signed by Patient if HCP Office has no BAA with Janssen

Enroll in Patients Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

Johnson & Johnson Patient Assistance Foundation Eligibility Check

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.